Abnormal metabolic screening suggestive of IEMs comprises a substantial proportion of pediatric NIE in our setting. Early metabolic screening coupled with readily available biomarkers (notably ammonia) may help prioritize patients for confirmatory testing and timely management.
Abdelrazic et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: